diabetes

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
CP Wire
Sun, 03/26/23 - 03:44 pm
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Sun, 03/26/23 - 03:36 pm
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
In insulin resistance pact, Dewpoint adds Novo Nordisk to its pharma-rich pipeline
Enpoints
Wed, 03/22/23 - 11:13 am
Dewpoint Therapeutics
Novo Nordisk
diabetes
insulin resistance
condensates
Six-month Ozempic shortage mostly over after weight-loss craze drained supply
Seattle Times, WA
Mon, 03/20/23 - 04:39 pm
Novo Nordisk
drug shortages
Ozempic
diabetes
weight loss
California takes another step forward in its insulin production with $50M investment
Endpoints
Mon, 03/20/23 - 04:37 pm
California
insulin
diabetes
Mer­ck, Vi­a­tris agree to set­tle patent feud sur­round­ing di­a­betes drugs
Endpoints
Mon, 03/20/23 - 04:30 pm
Merck
Viatris
patents
diabetes
Januvia
Janumet
Three's company: Sanofi follows lead of Lilly and Novo, slashes insulin price by 78% and caps out-of-pocket costs
Endpoints
Thu, 03/16/23 - 09:16 pm
Sanofi
Lantus
insulin
diabetes
drug pricing
Eli Lilly
Novo Nordisk
Strategy Behind Lowered Insulin Prices: Novo Nordisk and Eli Lilly
BioSpace
Wed, 03/15/23 - 10:06 am
insulin
diabetes
drug pricing
Eli Lilly
Novo Nordisk
Bayer study finds communication gap in managing chronic kidney disease in patients with type 2 diabetes
Medical Marketing and Media
Tue, 03/14/23 - 06:22 pm
Bayer
diabetes
chronic kidney disease
healthcare providers
physicians
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly
Forbes
Tue, 03/14/23 - 11:27 am
Novo Nordisk
drug pricing
insulin
diabetes
Eli Lilly
CRISPR/ViaCyte and Genprex Vie for First Diabetes Gene Therapy
BioSpace
Mon, 03/13/23 - 10:21 am
ViaCyte
CRISPR Therapeutics
Genprex
diabetes
gene therapy
Sanofi throws down $2.9B to acquire diabetes partner Provention Bio
Fierce Pharma
Mon, 03/13/23 - 10:08 am
Sanofi
Provention Bio
M&A
diabetes
Eli Lilly kicks off consumer campaign for diabetes drug Mounjaro
Medical Marketing and Media
Thu, 03/9/23 - 11:26 am
Eli Lilly
Mounjaro
diabetes
DTC ads
Why does insulin cost so much? Big Pharma isn’t the only player driving prices
Medical Marketing and Media
Thu, 03/9/23 - 11:22 am
diabetes
insulin
drug pricing
8 Moments that Defined Diabetes Tech
Medical Devices and Diagnostics Industry
Tue, 03/7/23 - 10:26 pm
diabetes
Medtech
Medtronic
Sensionics
Verily
Embecta
DexCom
Apple
CMS
Abbott Labs
Abbott Scores a 'Long-Awaited Win' in Diabetes
Medical Devices and Diagnostics Industry
Mon, 03/6/23 - 11:25 pm
Abbott Labs
diabetes
Medtech
Freestyle Libre 2
FreeStyle Libre 3
FDA
Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance
CNBC
Wed, 03/1/23 - 10:10 am
Eli Lilly
drug pricing
diabetes
insulin
Humalog
Humalin
Should Abbott and DexCom Investors Be Worried About Apple's Latest News?
Motley Fool
Tue, 02/28/23 - 10:18 am
Medtech
diabetes
continuous glucose monitoring
Apple
DexCom
Abbott Labs
Medtronic links MiniMed 780G automated insulin delivery to sustained glucose control benefits
Medtech Dive
Mon, 02/27/23 - 10:10 am
Medtronic
devices
Medtech
diabetes
MiniMed 780G
type 1 diabetes
Apple making strides on noninvasive, continuous blood glucose monitoring for Apple Watch: report
Medical Marketing and Media
Wed, 02/22/23 - 06:56 pm
Apple
Apple Watch
devices
Medtech
wearables
diabetes
blood glucose monitoring

Pages